nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—Fosphenytoin—epilepsy syndrome	0.108	0.345	CrCtD
Modafinil—Phenytoin—epilepsy syndrome	0.0738	0.236	CrCtD
Modafinil—Carbamazepine—epilepsy syndrome	0.0682	0.218	CrCtD
Modafinil—Oxcarbazepine—epilepsy syndrome	0.0628	0.201	CrCtD
Modafinil—CYP2C19—epilepsy syndrome	0.0566	1	CbGaD
Modafinil—multiple sclerosis—Oxcarbazepine—epilepsy syndrome	0.0345	0.178	CpDpCtD
Modafinil—multiple sclerosis—Diazepam—epilepsy syndrome	0.0345	0.178	CpDpCtD
Modafinil—multiple sclerosis—Pregabalin—epilepsy syndrome	0.0293	0.152	CpDpCtD
Modafinil—multiple sclerosis—Carbamazepine—epilepsy syndrome	0.0261	0.135	CpDpCtD
Modafinil—multiple sclerosis—Clonazepam—epilepsy syndrome	0.0209	0.108	CpDpCtD
Modafinil—Parkinson's disease—Clonazepam—epilepsy syndrome	0.0172	0.0891	CpDpCtD
Modafinil—multiple sclerosis—Gabapentin—epilepsy syndrome	0.0168	0.0871	CpDpCtD
Modafinil—Fosphenytoin—Phenytoin—epilepsy syndrome	0.0144	0.0797	CrCrCtD
Modafinil—Parkinson's disease—Gabapentin—epilepsy syndrome	0.0139	0.0718	CpDpCtD
Modafinil—Phenytoin—Fosphenytoin—epilepsy syndrome	0.0099	0.0546	CrCrCtD
Modafinil—Phenytoin—Primidone—epilepsy syndrome	0.0099	0.0546	CrCrCtD
Modafinil—Phenylbutazone—Fosphenytoin—epilepsy syndrome	0.00948	0.0523	CrCrCtD
Modafinil—Phenytoin—Phenobarbital—epilepsy syndrome	0.0073	0.0403	CrCrCtD
Modafinil—Warfarin—Phenytoin—epilepsy syndrome	0.0071	0.0392	CrCrCtD
Modafinil—Phenindione—Fosphenytoin—epilepsy syndrome	0.00695	0.0383	CrCrCtD
Modafinil—Oxaprozin—Phenytoin—epilepsy syndrome	0.00678	0.0374	CrCrCtD
Modafinil—Nepafenac—Carbamazepine—epilepsy syndrome	0.00655	0.0362	CrCrCtD
Modafinil—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00651	0.0383	CbGbCtD
Modafinil—Phenylbutazone—Phenytoin—epilepsy syndrome	0.0065	0.0358	CrCrCtD
Modafinil—Oxaprozin—Carbamazepine—epilepsy syndrome	0.00626	0.0345	CrCrCtD
Modafinil—Phenytoin—Carbamazepine—epilepsy syndrome	0.00626	0.0345	CrCrCtD
Modafinil—Nepafenac—Oxcarbazepine—epilepsy syndrome	0.00604	0.0333	CrCrCtD
Modafinil—Warfarin—Oxcarbazepine—epilepsy syndrome	0.00604	0.0333	CrCrCtD
Modafinil—Phenprocoumon—Phenytoin—epilepsy syndrome	0.006	0.0331	CrCrCtD
Modafinil—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00587	0.0345	CbGbCtD
Modafinil—Carbamazepine—Phenytoin—epilepsy syndrome	0.00578	0.0319	CrCrCtD
Modafinil—CYP2B6—Clobazam—epilepsy syndrome	0.00564	0.0332	CbGbCtD
Modafinil—Antazoline—Phenytoin—epilepsy syndrome	0.00539	0.0297	CrCrCtD
Modafinil—Phenylbutazone—Clobazam—epilepsy syndrome	0.0053	0.0292	CrCrCtD
Modafinil—Carbamazepine—Oxcarbazepine—epilepsy syndrome	0.00491	0.0271	CrCrCtD
Modafinil—Phenindione—Phenytoin—epilepsy syndrome	0.00476	0.0263	CrCrCtD
Modafinil—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00473	0.0278	CbGbCtD
Modafinil—CYP2B6—Carbamazepine—epilepsy syndrome	0.00468	0.0275	CbGbCtD
Modafinil—Oxcarbazepine—Carbamazepine—epilepsy syndrome	0.00453	0.025	CrCrCtD
Modafinil—CYP2C19—Trimethadione—epilepsy syndrome	0.0044	0.0259	CbGbCtD
Modafinil—CYP2C19—Felbamate—epilepsy syndrome	0.0044	0.0259	CbGbCtD
Modafinil—Phenindione—Carbamazepine—epilepsy syndrome	0.0044	0.0243	CrCrCtD
Modafinil—CYP2B6—Primidone—epilepsy syndrome	0.00437	0.0257	CbGbCtD
Modafinil—CYP2B6—Phenytoin—epilepsy syndrome	0.00419	0.0247	CbGbCtD
Modafinil—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00414	0.0243	CbGbCtD
Modafinil—Phenindione—Oxcarbazepine—epilepsy syndrome	0.00405	0.0223	CrCrCtD
Modafinil—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.00405	0.0223	CrCrCtD
Modafinil—Oxcarbazepine—Clobazam—epilepsy syndrome	0.004	0.0221	CrCrCtD
Modafinil—CYP2B6—Propofol—epilepsy syndrome	0.00391	0.023	CbGbCtD
Modafinil—Phenindione—Clobazam—epilepsy syndrome	0.00388	0.0214	CrCrCtD
Modafinil—CYP2B6—Phenobarbital—epilepsy syndrome	0.00374	0.022	CbGbCtD
Modafinil—Oxcarbazepine—Diazepam—epilepsy syndrome	0.00372	0.0205	CrCrCtD
Modafinil—CYP2B6—Midazolam—epilepsy syndrome	0.00369	0.0217	CbGbCtD
Modafinil—CYP3A5—Carbamazepine—epilepsy syndrome	0.00368	0.0217	CbGbCtD
Modafinil—CYP2C9—Trimethadione—epilepsy syndrome	0.00366	0.0215	CbGbCtD
Modafinil—CYP2C19—Clobazam—epilepsy syndrome	0.00359	0.0211	CbGbCtD
Modafinil—CYP2B6—Diazepam—epilepsy syndrome	0.00354	0.0208	CbGbCtD
Modafinil—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00344	0.0202	CbGbCtD
Modafinil—CYP3A5—Phenytoin—epilepsy syndrome	0.0033	0.0194	CbGbCtD
Modafinil—Benzphetamine—Phenytoin—epilepsy syndrome	0.003	0.0165	CrCrCtD
Modafinil—CYP2C19—Carbamazepine—epilepsy syndrome	0.00297	0.0175	CbGbCtD
Modafinil—CYP3A5—Phenobarbital—epilepsy syndrome	0.00295	0.0173	CbGbCtD
Modafinil—CYP3A5—Midazolam—epilepsy syndrome	0.0029	0.0171	CbGbCtD
Modafinil—CYP2B6—Valproic Acid—epilepsy syndrome	0.00279	0.0164	CbGbCtD
Modafinil—CYP3A5—Diazepam—epilepsy syndrome	0.00279	0.0164	CbGbCtD
Modafinil—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.00278	0.0153	CrCrCtD
Modafinil—CYP2C19—Primidone—epilepsy syndrome	0.00277	0.0163	CbGbCtD
Modafinil—CYP1A2—Carbamazepine—epilepsy syndrome	0.00274	0.0161	CbGbCtD
Modafinil—CYP2C19—Phenytoin—epilepsy syndrome	0.00267	0.0157	CbGbCtD
Modafinil—Diphenhydramine—Phenytoin—epilepsy syndrome	0.00266	0.0147	CrCrCtD
Modafinil—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.00256	0.0141	CrCrCtD
Modafinil—CYP1A2—Primidone—epilepsy syndrome	0.00256	0.015	CbGbCtD
Modafinil—CYP2C19—Propofol—epilepsy syndrome	0.00249	0.0146	CbGbCtD
Modafinil—CYP2C9—Carbamazepine—epilepsy syndrome	0.00247	0.0145	CbGbCtD
Modafinil—CYP2C19—Phenobarbital—epilepsy syndrome	0.00238	0.014	CbGbCtD
Modafinil—CYP2C9—Primidone—epilepsy syndrome	0.00231	0.0136	CbGbCtD
Modafinil—CYP1A2—Propofol—epilepsy syndrome	0.00229	0.0135	CbGbCtD
Modafinil—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00229	0.0134	CbGbCtD
Modafinil—CYP2C19—Diazepam—epilepsy syndrome	0.00225	0.0132	CbGbCtD
Modafinil—CYP2C9—Phenytoin—epilepsy syndrome	0.00222	0.013	CbGbCtD
Modafinil—CYP3A5—Valproic Acid—epilepsy syndrome	0.0022	0.0129	CbGbCtD
Modafinil—CYP2C19—Zonisamide—epilepsy syndrome	0.0022	0.0129	CbGbCtD
Modafinil—CYP1A2—Phenobarbital—epilepsy syndrome	0.00219	0.0129	CbGbCtD
Modafinil—CYP3A4—Trimethadione—epilepsy syndrome	0.00213	0.0125	CbGbCtD
Modafinil—CYP3A4—Felbamate—epilepsy syndrome	0.00213	0.0125	CbGbCtD
Modafinil—CYP1A2—Diazepam—epilepsy syndrome	0.00208	0.0122	CbGbCtD
Modafinil—CYP2C9—Propofol—epilepsy syndrome	0.00207	0.0121	CbGbCtD
Modafinil—CYP3A4—Fosphenytoin—epilepsy syndrome	0.002	0.0118	CbGbCtD
Modafinil—CYP2C9—Phenobarbital—epilepsy syndrome	0.00198	0.0116	CbGbCtD
Modafinil—CYP2C9—Diazepam—epilepsy syndrome	0.00187	0.011	CbGbCtD
Modafinil—CYP3A4—Clonazepam—epilepsy syndrome	0.00181	0.0106	CbGbCtD
Modafinil—CYP2C19—Valproic Acid—epilepsy syndrome	0.00178	0.0104	CbGbCtD
Modafinil—CYP3A4—Clobazam—epilepsy syndrome	0.00173	0.0102	CbGbCtD
Modafinil—CYP1A2—Valproic Acid—epilepsy syndrome	0.00164	0.00963	CbGbCtD
Modafinil—CYP2C19—Topiramate—epilepsy syndrome	0.0016	0.00941	CbGbCtD
Modafinil—CYP2C9—Valproic Acid—epilepsy syndrome	0.00148	0.00867	CbGbCtD
Modafinil—CYP3A4—Rufinamide—epilepsy syndrome	0.00147	0.00866	CbGbCtD
Modafinil—CYP3A4—Carbamazepine—epilepsy syndrome	0.00144	0.00844	CbGbCtD
Modafinil—CYP3A4—Primidone—epilepsy syndrome	0.00134	0.00788	CbGbCtD
Modafinil—CYP3A4—Phenytoin—epilepsy syndrome	0.00129	0.00757	CbGbCtD
Modafinil—CYP3A4—Propofol—epilepsy syndrome	0.0012	0.00706	CbGbCtD
Modafinil—CYP3A4—Phenobarbital—epilepsy syndrome	0.00115	0.00675	CbGbCtD
Modafinil—CYP3A4—Acetazolamide—epilepsy syndrome	0.00115	0.00675	CbGbCtD
Modafinil—CYP3A4—Midazolam—epilepsy syndrome	0.00113	0.00666	CbGbCtD
Modafinil—CYP3A4—Diazepam—epilepsy syndrome	0.00109	0.0064	CbGbCtD
Modafinil—CYP3A4—Zonisamide—epilepsy syndrome	0.00106	0.00625	CbGbCtD
Modafinil—CYP3A4—Valproic Acid—epilepsy syndrome	0.000858	0.00504	CbGbCtD
Modafinil—CYP3A4—Topiramate—epilepsy syndrome	0.000774	0.00455	CbGbCtD
Modafinil—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.000228	0.199	CbGeAlD
Modafinil—SLC6A3—ganglion—epilepsy syndrome	0.000142	0.124	CbGeAlD
Modafinil—SLC6A3—hindbrain—epilepsy syndrome	0.000108	0.0938	CbGeAlD
Modafinil—SLC6A3—brainstem—epilepsy syndrome	6.17e-05	0.0537	CbGeAlD
Modafinil—SLC6A3—forebrain—epilepsy syndrome	5.95e-05	0.0519	CbGeAlD
Modafinil—Phenytoin—SCN8A—epilepsy syndrome	5.74e-05	0.0373	CrCbGaD
Modafinil—Methadyl Acetate—OPRM1—epilepsy syndrome	5.55e-05	0.0361	CrCbGaD
Modafinil—SLC6A3—telencephalon—epilepsy syndrome	5.47e-05	0.0477	CbGeAlD
Modafinil—Dimenhydrinate—CHRM2—epilepsy syndrome	5.36e-05	0.0349	CrCbGaD
Modafinil—Tropicamide—CHRM3—epilepsy syndrome	5.33e-05	0.0347	CrCbGaD
Modafinil—Tropicamide—CHRM1—epilepsy syndrome	4.97e-05	0.0324	CrCbGaD
Modafinil—Carbamazepine—SCN9A—epilepsy syndrome	4.77e-05	0.0311	CrCbGaD
Modafinil—Cinnarizine—CACNA1G—epilepsy syndrome	4.74e-05	0.0309	CrCbGaD
Modafinil—Phenytoin—SCN9A—epilepsy syndrome	4.64e-05	0.0302	CrCbGaD
Modafinil—ADRA1B—head—epilepsy syndrome	4.55e-05	0.0396	CbGeAlD
Modafinil—Phenytoin—SCN3A—epilepsy syndrome	4.44e-05	0.0289	CrCbGaD
Modafinil—Carbamazepine—SCN4A—epilepsy syndrome	4.39e-05	0.0286	CrCbGaD
Modafinil—Isopropamide—CHRM3—epilepsy syndrome	4.35e-05	0.0283	CrCbGaD
Modafinil—ADRA1B—nervous system—epilepsy syndrome	4.31e-05	0.0376	CbGeAlD
Modafinil—Cinnarizine—CACNA1H—epilepsy syndrome	4.27e-05	0.0278	CrCbGaD
Modafinil—Phenytoin—SCN4A—epilepsy syndrome	4.26e-05	0.0277	CrCbGaD
Modafinil—ADRA1B—central nervous system—epilepsy syndrome	4.15e-05	0.0362	CbGeAlD
Modafinil—Tropicamide—CHRM2—epilepsy syndrome	4.06e-05	0.0264	CrCbGaD
Modafinil—Isopropamide—CHRM1—epilepsy syndrome	4.05e-05	0.0264	CrCbGaD
Modafinil—Cinnarizine—CACNA1D—epilepsy syndrome	4.03e-05	0.0263	CrCbGaD
Modafinil—SLC6A3—midbrain—epilepsy syndrome	3.93e-05	0.0342	CbGeAlD
Modafinil—SLC6A3—spinal cord—epilepsy syndrome	3.83e-05	0.0334	CbGeAlD
Modafinil—Orphenadrine—SCN9A—epilepsy syndrome	3.44e-05	0.0224	CrCbGaD
Modafinil—SLC6A3—head—epilepsy syndrome	3.41e-05	0.0297	CbGeAlD
Modafinil—ADRA1B—brain—epilepsy syndrome	3.3e-05	0.0287	CbGeAlD
Modafinil—SLC6A3—nervous system—epilepsy syndrome	3.23e-05	0.0282	CbGeAlD
Modafinil—Orphenadrine—SCN4A—epilepsy syndrome	3.16e-05	0.0206	CrCbGaD
Modafinil—Ketoprofen—SLCO1A2—epilepsy syndrome	3.13e-05	0.0204	CrCbGaD
Modafinil—Phenytoin—SCN1A—epilepsy syndrome	3.11e-05	0.0203	CrCbGaD
Modafinil—SLC6A3—central nervous system—epilepsy syndrome	3.11e-05	0.0271	CbGeAlD
Modafinil—SLC6A3—cerebellum—epilepsy syndrome	3.04e-05	0.0265	CbGeAlD
Modafinil—Benzatropine—CHRM1—epilepsy syndrome	2.96e-05	0.0193	CrCbGaD
Modafinil—Phenytoin—SCN2A—epilepsy syndrome	2.75e-05	0.0179	CrCbGaD
Modafinil—Dextropropoxyphene—OPRD1—epilepsy syndrome	2.73e-05	0.0178	CrCbGaD
Modafinil—Fentanyl—OPRD1—epilepsy syndrome	2.7e-05	0.0176	CrCbGaD
Modafinil—SLC6A3—brain—epilepsy syndrome	2.47e-05	0.0215	CbGeAlD
Modafinil—Levomethadyl Acetate—OPRM1—epilepsy syndrome	2.42e-05	0.0157	CrCbGaD
Modafinil—Benzatropine—CHRM2—epilepsy syndrome	2.41e-05	0.0157	CrCbGaD
Modafinil—Orphenadrine—SCN1A—epilepsy syndrome	2.31e-05	0.015	CrCbGaD
Modafinil—Fosphenytoin—CYP2C19—epilepsy syndrome	2.22e-05	0.0144	CrCbGaD
Modafinil—Dextropropoxyphene—OPRM1—epilepsy syndrome	2.09e-05	0.0136	CrCbGaD
Modafinil—Fentanyl—OPRM1—epilepsy syndrome	2.07e-05	0.0134	CrCbGaD
Modafinil—CYP2B6—head—epilepsy syndrome	2.03e-05	0.0177	CbGeAlD
Modafinil—CYP2B6—nervous system—epilepsy syndrome	1.92e-05	0.0167	CbGeAlD
Modafinil—Methadone—OPRD1—epilepsy syndrome	1.85e-05	0.0121	CrCbGaD
Modafinil—CYP2B6—central nervous system—epilepsy syndrome	1.85e-05	0.0161	CbGeAlD
Modafinil—Bifonazole—CYP2C19—epilepsy syndrome	1.68e-05	0.0109	CrCbGaD
Modafinil—Nepafenac—PTGS2—epilepsy syndrome	1.6e-05	0.0104	CrCbGaD
Modafinil—Benzatropine—CYP2C19—epilepsy syndrome	1.49e-05	0.0097	CrCbGaD
Modafinil—Oxcarbazepine—CYP2C19—epilepsy syndrome	1.48e-05	0.00961	CrCbGaD
Modafinil—CYP2B6—brain—epilepsy syndrome	1.47e-05	0.0128	CbGeAlD
Modafinil—CYP3A4—nervous system—epilepsy syndrome	1.45e-05	0.0126	CbGeAlD
Modafinil—Carbamazepine—ABCC2—epilepsy syndrome	1.45e-05	0.00943	CrCbGaD
Modafinil—Methadone—OPRM1—epilepsy syndrome	1.42e-05	0.00922	CrCbGaD
Modafinil—Phenytoin—ABCC2—epilepsy syndrome	1.41e-05	0.00916	CrCbGaD
Modafinil—CYP3A4—central nervous system—epilepsy syndrome	1.4e-05	0.0122	CbGeAlD
Modafinil—Warfarin—CYP2C19—epilepsy syndrome	1.35e-05	0.00877	CrCbGaD
Modafinil—Oxaprozin—PTGS2—epilepsy syndrome	1.33e-05	0.00864	CrCbGaD
Modafinil—Benzphetamine—ADRA2A—epilepsy syndrome	1.32e-05	0.00861	CrCbGaD
Modafinil—Phenoxybenzamine—ADRA2A—epilepsy syndrome	1.26e-05	0.00823	CrCbGaD
Modafinil—Diphenhydramine—CHRM2—epilepsy syndrome	1.24e-05	0.00808	CrCbGaD
Modafinil—Fosphenytoin—ALB—epilepsy syndrome	1.23e-05	0.008	CrCbGaD
Modafinil—Orphenadrine—CHRM2—epilepsy syndrome	1.17e-05	0.00765	CrCbGaD
Modafinil—Benzatropine—CYP2D6—epilepsy syndrome	1.1e-05	0.00719	CrCbGaD
Modafinil—Fenoprofen—PTGS2—epilepsy syndrome	1.1e-05	0.00714	CrCbGaD
Modafinil—Myalgia—Pregabalin—epilepsy syndrome	1.08e-05	0.000163	CcSEcCtD
Modafinil—Arthralgia—Pregabalin—epilepsy syndrome	1.08e-05	0.000163	CcSEcCtD
Modafinil—Chest pain—Pregabalin—epilepsy syndrome	1.08e-05	0.000163	CcSEcCtD
Modafinil—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.08e-05	0.000162	CcSEcCtD
Modafinil—Dizziness—Zonisamide—epilepsy syndrome	1.08e-05	0.000162	CcSEcCtD
Modafinil—Headache—Diazepam—epilepsy syndrome	1.08e-05	0.000162	CcSEcCtD
Modafinil—Anxiety—Pregabalin—epilepsy syndrome	1.08e-05	0.000162	CcSEcCtD
Modafinil—Diarrhoea—Clonazepam—epilepsy syndrome	1.08e-05	0.000162	CcSEcCtD
Modafinil—Anaemia—Gabapentin—epilepsy syndrome	1.08e-05	0.000162	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.07e-05	0.000161	CcSEcCtD
Modafinil—Hypotension—Valproic Acid—epilepsy syndrome	1.07e-05	0.000161	CcSEcCtD
Modafinil—Asthenia—Carbamazepine—epilepsy syndrome	1.07e-05	0.000161	CcSEcCtD
Modafinil—Agitation—Gabapentin—epilepsy syndrome	1.07e-05	0.000161	CcSEcCtD
Modafinil—Diarrhoea—Phenytoin—epilepsy syndrome	1.07e-05	0.000161	CcSEcCtD
Modafinil—Discomfort—Pregabalin—epilepsy syndrome	1.07e-05	0.000161	CcSEcCtD
Modafinil—Nausea—Fosphenytoin—epilepsy syndrome	1.07e-05	0.000161	CcSEcCtD
Modafinil—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.07e-05	0.00016	CcSEcCtD
Modafinil—Erythema multiforme—Topiramate—epilepsy syndrome	1.07e-05	0.00016	CcSEcCtD
Modafinil—Angioedema—Gabapentin—epilepsy syndrome	1.06e-05	0.00016	CcSEcCtD
Modafinil—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.06e-05	0.00016	CcSEcCtD
Modafinil—Vomiting—Felbamate—epilepsy syndrome	1.06e-05	0.00016	CcSEcCtD
Modafinil—Dry mouth—Pregabalin—epilepsy syndrome	1.06e-05	0.000159	CcSEcCtD
Modafinil—Pruritus—Carbamazepine—epilepsy syndrome	1.06e-05	0.000159	CcSEcCtD
Modafinil—Rash—Felbamate—epilepsy syndrome	1.05e-05	0.000158	CcSEcCtD
Modafinil—Dermatitis—Felbamate—epilepsy syndrome	1.05e-05	0.000158	CcSEcCtD
Modafinil—Malaise—Gabapentin—epilepsy syndrome	1.05e-05	0.000158	CcSEcCtD
Modafinil—Vertigo—Gabapentin—epilepsy syndrome	1.05e-05	0.000157	CcSEcCtD
Modafinil—Headache—Felbamate—epilepsy syndrome	1.05e-05	0.000157	CcSEcCtD
Modafinil—Confusional state—Pregabalin—epilepsy syndrome	1.05e-05	0.000157	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.05e-05	0.000157	CcSEcCtD
Modafinil—Cardiac disorder—Topiramate—epilepsy syndrome	1.05e-05	0.000157	CcSEcCtD
Modafinil—Syncope—Gabapentin—epilepsy syndrome	1.05e-05	0.000157	CcSEcCtD
Modafinil—Dizziness—Clonazepam—epilepsy syndrome	1.04e-05	0.000157	CcSEcCtD
Modafinil—Nausea—Vigabatrin—epilepsy syndrome	1.04e-05	0.000156	CcSEcCtD
Modafinil—Vomiting—Zonisamide—epilepsy syndrome	1.04e-05	0.000156	CcSEcCtD
Modafinil—Insomnia—Valproic Acid—epilepsy syndrome	1.04e-05	0.000156	CcSEcCtD
Modafinil—Oedema—Pregabalin—epilepsy syndrome	1.04e-05	0.000156	CcSEcCtD
Modafinil—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.04e-05	0.000156	CcSEcCtD
Modafinil—Asthenia—Lamotrigine—epilepsy syndrome	1.04e-05	0.000156	CcSEcCtD
Modafinil—Dizziness—Phenytoin—epilepsy syndrome	1.04e-05	0.000156	CcSEcCtD
Modafinil—Rash—Zonisamide—epilepsy syndrome	1.03e-05	0.000155	CcSEcCtD
Modafinil—Infection—Pregabalin—epilepsy syndrome	1.03e-05	0.000155	CcSEcCtD
Modafinil—Paraesthesia—Valproic Acid—epilepsy syndrome	1.03e-05	0.000155	CcSEcCtD
Modafinil—Palpitations—Gabapentin—epilepsy syndrome	1.03e-05	0.000155	CcSEcCtD
Modafinil—Dermatitis—Zonisamide—epilepsy syndrome	1.03e-05	0.000155	CcSEcCtD
Modafinil—Dizziness—Oxcarbazepine—epilepsy syndrome	1.03e-05	0.000155	CcSEcCtD
Modafinil—Nausea—Diazepam—epilepsy syndrome	1.03e-05	0.000154	CcSEcCtD
Modafinil—Loss of consciousness—Gabapentin—epilepsy syndrome	1.02e-05	0.000154	CcSEcCtD
Modafinil—Headache—Zonisamide—epilepsy syndrome	1.02e-05	0.000154	CcSEcCtD
Modafinil—Dyspnoea—Valproic Acid—epilepsy syndrome	1.02e-05	0.000154	CcSEcCtD
Modafinil—Diarrhoea—Carbamazepine—epilepsy syndrome	1.02e-05	0.000154	CcSEcCtD
Modafinil—Angiopathy—Topiramate—epilepsy syndrome	1.02e-05	0.000154	CcSEcCtD
Modafinil—Pruritus—Lamotrigine—epilepsy syndrome	1.02e-05	0.000153	CcSEcCtD
Modafinil—Shock—Pregabalin—epilepsy syndrome	1.02e-05	0.000153	CcSEcCtD
Modafinil—Somnolence—Valproic Acid—epilepsy syndrome	1.02e-05	0.000153	CcSEcCtD
Modafinil—Immune system disorder—Topiramate—epilepsy syndrome	1.02e-05	0.000153	CcSEcCtD
Modafinil—Nervous system disorder—Pregabalin—epilepsy syndrome	1.02e-05	0.000153	CcSEcCtD
Modafinil—Cough—Gabapentin—epilepsy syndrome	1.02e-05	0.000153	CcSEcCtD
Modafinil—Mediastinal disorder—Topiramate—epilepsy syndrome	1.02e-05	0.000153	CcSEcCtD
Modafinil—Tachycardia—Pregabalin—epilepsy syndrome	1.01e-05	0.000152	CcSEcCtD
Modafinil—Chills—Topiramate—epilepsy syndrome	1.01e-05	0.000152	CcSEcCtD
Modafinil—Dyspepsia—Valproic Acid—epilepsy syndrome	1.01e-05	0.000152	CcSEcCtD
Modafinil—Convulsion—Gabapentin—epilepsy syndrome	1.01e-05	0.000152	CcSEcCtD
Modafinil—Skin disorder—Pregabalin—epilepsy syndrome	1.01e-05	0.000151	CcSEcCtD
Modafinil—Carbamazepine—CYP2C19—epilepsy syndrome	1.01e-05	0.00655	CrCbGaD
Modafinil—Hypertension—Gabapentin—epilepsy syndrome	1.01e-05	0.000151	CcSEcCtD
Modafinil—Hyperhidrosis—Pregabalin—epilepsy syndrome	1e-05	0.000151	CcSEcCtD
Modafinil—Vomiting—Clonazepam—epilepsy syndrome	1e-05	0.000151	CcSEcCtD
Modafinil—Atomoxetine—SLC6A4—epilepsy syndrome	1e-05	0.00652	CrCbGaD
Modafinil—Decreased appetite—Valproic Acid—epilepsy syndrome	9.97e-06	0.00015	CcSEcCtD
Modafinil—Vomiting—Phenytoin—epilepsy syndrome	9.95e-06	0.00015	CcSEcCtD
Modafinil—Rash—Clonazepam—epilepsy syndrome	9.94e-06	0.000149	CcSEcCtD
Modafinil—Dermatitis—Clonazepam—epilepsy syndrome	9.93e-06	0.000149	CcSEcCtD
Modafinil—Arthralgia—Gabapentin—epilepsy syndrome	9.92e-06	0.000149	CcSEcCtD
Modafinil—Chest pain—Gabapentin—epilepsy syndrome	9.92e-06	0.000149	CcSEcCtD
Modafinil—Myalgia—Gabapentin—epilepsy syndrome	9.92e-06	0.000149	CcSEcCtD
Modafinil—Nausea—Felbamate—epilepsy syndrome	9.92e-06	0.000149	CcSEcCtD
Modafinil—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.91e-06	0.000149	CcSEcCtD
Modafinil—Vomiting—Oxcarbazepine—epilepsy syndrome	9.9e-06	0.000149	CcSEcCtD
Modafinil—Fatigue—Valproic Acid—epilepsy syndrome	9.89e-06	0.000149	CcSEcCtD
Modafinil—Anxiety—Gabapentin—epilepsy syndrome	9.89e-06	0.000149	CcSEcCtD
Modafinil—Anorexia—Pregabalin—epilepsy syndrome	9.89e-06	0.000149	CcSEcCtD
Modafinil—Dizziness—Carbamazepine—epilepsy syndrome	9.88e-06	0.000148	CcSEcCtD
Modafinil—Diarrhoea—Lamotrigine—epilepsy syndrome	9.88e-06	0.000148	CcSEcCtD
Modafinil—Headache—Clonazepam—epilepsy syndrome	9.87e-06	0.000148	CcSEcCtD
Modafinil—Rash—Phenytoin—epilepsy syndrome	9.87e-06	0.000148	CcSEcCtD
Modafinil—Mental disorder—Topiramate—epilepsy syndrome	9.87e-06	0.000148	CcSEcCtD
Modafinil—Dermatitis—Phenytoin—epilepsy syndrome	9.86e-06	0.000148	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	9.85e-06	0.000148	CcSEcCtD
Modafinil—Rash—Oxcarbazepine—epilepsy syndrome	9.82e-06	0.000147	CcSEcCtD
Modafinil—Constipation—Valproic Acid—epilepsy syndrome	9.81e-06	0.000147	CcSEcCtD
Modafinil—Pain—Valproic Acid—epilepsy syndrome	9.81e-06	0.000147	CcSEcCtD
Modafinil—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.81e-06	0.000147	CcSEcCtD
Modafinil—Headache—Phenytoin—epilepsy syndrome	9.81e-06	0.000147	CcSEcCtD
Modafinil—Malnutrition—Topiramate—epilepsy syndrome	9.81e-06	0.000147	CcSEcCtD
Modafinil—Discomfort—Gabapentin—epilepsy syndrome	9.8e-06	0.000147	CcSEcCtD
Modafinil—Phenytoin—CYP2C19—epilepsy syndrome	9.78e-06	0.00637	CrCbGaD
Modafinil—Fenoprofen—ALB—epilepsy syndrome	9.77e-06	0.00636	CrCbGaD
Modafinil—Headache—Oxcarbazepine—epilepsy syndrome	9.75e-06	0.000147	CcSEcCtD
Modafinil—Nausea—Zonisamide—epilepsy syndrome	9.71e-06	0.000146	CcSEcCtD
Modafinil—Dry mouth—Gabapentin—epilepsy syndrome	9.7e-06	0.000146	CcSEcCtD
Modafinil—Hypotension—Pregabalin—epilepsy syndrome	9.69e-06	0.000146	CcSEcCtD
Modafinil—Flatulence—Topiramate—epilepsy syndrome	9.66e-06	0.000145	CcSEcCtD
Modafinil—Tension—Topiramate—epilepsy syndrome	9.62e-06	0.000145	CcSEcCtD
Modafinil—Dysgeusia—Topiramate—epilepsy syndrome	9.6e-06	0.000144	CcSEcCtD
Modafinil—Confusional state—Gabapentin—epilepsy syndrome	9.59e-06	0.000144	CcSEcCtD
Modafinil—Dizziness—Lamotrigine—epilepsy syndrome	9.55e-06	0.000143	CcSEcCtD
Modafinil—Nervousness—Topiramate—epilepsy syndrome	9.52e-06	0.000143	CcSEcCtD
Modafinil—Anaphylactic shock—Gabapentin—epilepsy syndrome	9.51e-06	0.000143	CcSEcCtD
Modafinil—Oedema—Gabapentin—epilepsy syndrome	9.51e-06	0.000143	CcSEcCtD
Modafinil—Vomiting—Carbamazepine—epilepsy syndrome	9.5e-06	0.000143	CcSEcCtD
Modafinil—Atomoxetine—CYP2C19—epilepsy syndrome	9.49e-06	0.00618	CrCbGaD
Modafinil—Back pain—Topiramate—epilepsy syndrome	9.49e-06	0.000143	CcSEcCtD
Modafinil—Feeling abnormal—Valproic Acid—epilepsy syndrome	9.46e-06	0.000142	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.45e-06	0.000142	CcSEcCtD
Modafinil—Infection—Gabapentin—epilepsy syndrome	9.45e-06	0.000142	CcSEcCtD
Modafinil—Muscle spasms—Topiramate—epilepsy syndrome	9.43e-06	0.000142	CcSEcCtD
Modafinil—Rash—Carbamazepine—epilepsy syndrome	9.42e-06	0.000142	CcSEcCtD
Modafinil—Dermatitis—Carbamazepine—epilepsy syndrome	9.41e-06	0.000141	CcSEcCtD
Modafinil—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.38e-06	0.000141	CcSEcCtD
Modafinil—Insomnia—Pregabalin—epilepsy syndrome	9.38e-06	0.000141	CcSEcCtD
Modafinil—Nausea—Clonazepam—epilepsy syndrome	9.36e-06	0.000141	CcSEcCtD
Modafinil—Headache—Carbamazepine—epilepsy syndrome	9.36e-06	0.000141	CcSEcCtD
Modafinil—Shock—Gabapentin—epilepsy syndrome	9.36e-06	0.000141	CcSEcCtD
Modafinil—Nervous system disorder—Gabapentin—epilepsy syndrome	9.33e-06	0.00014	CcSEcCtD
Modafinil—Paraesthesia—Pregabalin—epilepsy syndrome	9.31e-06	0.00014	CcSEcCtD
Modafinil—Nausea—Phenytoin—epilepsy syndrome	9.3e-06	0.00014	CcSEcCtD
Modafinil—Tachycardia—Gabapentin—epilepsy syndrome	9.28e-06	0.000139	CcSEcCtD
Modafinil—Dyspnoea—Pregabalin—epilepsy syndrome	9.25e-06	0.000139	CcSEcCtD
Modafinil—Nausea—Oxcarbazepine—epilepsy syndrome	9.25e-06	0.000139	CcSEcCtD
Modafinil—Skin disorder—Gabapentin—epilepsy syndrome	9.24e-06	0.000139	CcSEcCtD
Modafinil—Somnolence—Pregabalin—epilepsy syndrome	9.22e-06	0.000139	CcSEcCtD
Modafinil—Hyperhidrosis—Gabapentin—epilepsy syndrome	9.2e-06	0.000138	CcSEcCtD
Modafinil—Tremor—Topiramate—epilepsy syndrome	9.19e-06	0.000138	CcSEcCtD
Modafinil—Vomiting—Lamotrigine—epilepsy syndrome	9.18e-06	0.000138	CcSEcCtD
Modafinil—Urticaria—Valproic Acid—epilepsy syndrome	9.12e-06	0.000137	CcSEcCtD
Modafinil—Rash—Lamotrigine—epilepsy syndrome	9.1e-06	0.000137	CcSEcCtD
Modafinil—Ill-defined disorder—Topiramate—epilepsy syndrome	9.1e-06	0.000137	CcSEcCtD
Modafinil—Dermatitis—Lamotrigine—epilepsy syndrome	9.1e-06	0.000137	CcSEcCtD
Modafinil—Abdominal pain—Valproic Acid—epilepsy syndrome	9.07e-06	0.000136	CcSEcCtD
Modafinil—Body temperature increased—Valproic Acid—epilepsy syndrome	9.07e-06	0.000136	CcSEcCtD
Modafinil—Anorexia—Gabapentin—epilepsy syndrome	9.07e-06	0.000136	CcSEcCtD
Modafinil—Anaemia—Topiramate—epilepsy syndrome	9.06e-06	0.000136	CcSEcCtD
Modafinil—Headache—Lamotrigine—epilepsy syndrome	9.05e-06	0.000136	CcSEcCtD
Modafinil—Decreased appetite—Pregabalin—epilepsy syndrome	9.02e-06	0.000135	CcSEcCtD
Modafinil—Agitation—Topiramate—epilepsy syndrome	9.01e-06	0.000135	CcSEcCtD
Modafinil—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.96e-06	0.000135	CcSEcCtD
Modafinil—Fatigue—Pregabalin—epilepsy syndrome	8.94e-06	0.000134	CcSEcCtD
Modafinil—Hypotension—Gabapentin—epilepsy syndrome	8.89e-06	0.000134	CcSEcCtD
Modafinil—Nausea—Carbamazepine—epilepsy syndrome	8.87e-06	0.000133	CcSEcCtD
Modafinil—Pain—Pregabalin—epilepsy syndrome	8.87e-06	0.000133	CcSEcCtD
Modafinil—Constipation—Pregabalin—epilepsy syndrome	8.87e-06	0.000133	CcSEcCtD
Modafinil—Malaise—Topiramate—epilepsy syndrome	8.84e-06	0.000133	CcSEcCtD
Modafinil—Vertigo—Topiramate—epilepsy syndrome	8.81e-06	0.000132	CcSEcCtD
Modafinil—Syncope—Topiramate—epilepsy syndrome	8.79e-06	0.000132	CcSEcCtD
Modafinil—Phenylbutazone—PTGS2—epilepsy syndrome	8.77e-06	0.00571	CrCbGaD
Modafinil—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.67e-06	0.00013	CcSEcCtD
Modafinil—Palpitations—Topiramate—epilepsy syndrome	8.67e-06	0.00013	CcSEcCtD
Modafinil—Loss of consciousness—Topiramate—epilepsy syndrome	8.62e-06	0.000129	CcSEcCtD
Modafinil—Insomnia—Gabapentin—epilepsy syndrome	8.6e-06	0.000129	CcSEcCtD
Modafinil—Nausea—Lamotrigine—epilepsy syndrome	8.58e-06	0.000129	CcSEcCtD
Modafinil—Cough—Topiramate—epilepsy syndrome	8.56e-06	0.000129	CcSEcCtD
Modafinil—Feeling abnormal—Pregabalin—epilepsy syndrome	8.55e-06	0.000128	CcSEcCtD
Modafinil—Paraesthesia—Gabapentin—epilepsy syndrome	8.54e-06	0.000128	CcSEcCtD
Modafinil—Convulsion—Topiramate—epilepsy syndrome	8.5e-06	0.000128	CcSEcCtD
Modafinil—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.48e-06	0.000127	CcSEcCtD
Modafinil—Dyspnoea—Gabapentin—epilepsy syndrome	8.48e-06	0.000127	CcSEcCtD
Modafinil—Hypertension—Topiramate—epilepsy syndrome	8.47e-06	0.000127	CcSEcCtD
Modafinil—Somnolence—Gabapentin—epilepsy syndrome	8.46e-06	0.000127	CcSEcCtD
Modafinil—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.45e-06	0.000127	CcSEcCtD
Modafinil—Phenprocoumon—ALB—epilepsy syndrome	8.42e-06	0.00548	CrCbGaD
Modafinil—Dyspepsia—Gabapentin—epilepsy syndrome	8.37e-06	0.000126	CcSEcCtD
Modafinil—Arthralgia—Topiramate—epilepsy syndrome	8.35e-06	0.000125	CcSEcCtD
Modafinil—Chest pain—Topiramate—epilepsy syndrome	8.35e-06	0.000125	CcSEcCtD
Modafinil—Myalgia—Topiramate—epilepsy syndrome	8.35e-06	0.000125	CcSEcCtD
Modafinil—Anxiety—Topiramate—epilepsy syndrome	8.32e-06	0.000125	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	8.29e-06	0.000125	CcSEcCtD
Modafinil—Decreased appetite—Gabapentin—epilepsy syndrome	8.27e-06	0.000124	CcSEcCtD
Modafinil—Discomfort—Topiramate—epilepsy syndrome	8.25e-06	0.000124	CcSEcCtD
Modafinil—Urticaria—Pregabalin—epilepsy syndrome	8.24e-06	0.000124	CcSEcCtD
Modafinil—Asthenia—Valproic Acid—epilepsy syndrome	8.23e-06	0.000124	CcSEcCtD
Modafinil—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	8.21e-06	0.000123	CcSEcCtD
Modafinil—Fatigue—Gabapentin—epilepsy syndrome	8.2e-06	0.000123	CcSEcCtD
Modafinil—Body temperature increased—Pregabalin—epilepsy syndrome	8.2e-06	0.000123	CcSEcCtD
Modafinil—Abdominal pain—Pregabalin—epilepsy syndrome	8.2e-06	0.000123	CcSEcCtD
Modafinil—Oxcarbazepine—ALB—epilepsy syndrome	8.19e-06	0.00533	CrCbGaD
Modafinil—Dry mouth—Topiramate—epilepsy syndrome	8.16e-06	0.000123	CcSEcCtD
Modafinil—Pain—Gabapentin—epilepsy syndrome	8.13e-06	0.000122	CcSEcCtD
Modafinil—Constipation—Gabapentin—epilepsy syndrome	8.13e-06	0.000122	CcSEcCtD
Modafinil—Pruritus—Valproic Acid—epilepsy syndrome	8.12e-06	0.000122	CcSEcCtD
Modafinil—Dextropropoxyphene—CYP2D6—epilepsy syndrome	8.09e-06	0.00526	CrCbGaD
Modafinil—Confusional state—Topiramate—epilepsy syndrome	8.07e-06	0.000121	CcSEcCtD
Modafinil—Oedema—Topiramate—epilepsy syndrome	8e-06	0.00012	CcSEcCtD
Modafinil—Infection—Topiramate—epilepsy syndrome	7.95e-06	0.000119	CcSEcCtD
Modafinil—Cinnarizine—CYP2D6—epilepsy syndrome	7.91e-06	0.00515	CrCbGaD
Modafinil—Shock—Topiramate—epilepsy syndrome	7.87e-06	0.000118	CcSEcCtD
Modafinil—Diarrhoea—Valproic Acid—epilepsy syndrome	7.85e-06	0.000118	CcSEcCtD
Modafinil—Nervous system disorder—Topiramate—epilepsy syndrome	7.85e-06	0.000118	CcSEcCtD
Modafinil—Feeling abnormal—Gabapentin—epilepsy syndrome	7.84e-06	0.000118	CcSEcCtD
Modafinil—Tachycardia—Topiramate—epilepsy syndrome	7.81e-06	0.000117	CcSEcCtD
Modafinil—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.78e-06	0.000117	CcSEcCtD
Modafinil—Skin disorder—Topiramate—epilepsy syndrome	7.77e-06	0.000117	CcSEcCtD
Modafinil—Hyperhidrosis—Topiramate—epilepsy syndrome	7.74e-06	0.000116	CcSEcCtD
Modafinil—Atomoxetine—HTR2A—epilepsy syndrome	7.69e-06	0.00501	CrCbGaD
Modafinil—Diphenhydramine—CYP2C19—epilepsy syndrome	7.66e-06	0.00499	CrCbGaD
Modafinil—Hypersensitivity—Pregabalin—epilepsy syndrome	7.64e-06	0.000115	CcSEcCtD
Modafinil—Anorexia—Topiramate—epilepsy syndrome	7.63e-06	0.000115	CcSEcCtD
Modafinil—Dizziness—Valproic Acid—epilepsy syndrome	7.59e-06	0.000114	CcSEcCtD
Modafinil—Urticaria—Gabapentin—epilepsy syndrome	7.56e-06	0.000114	CcSEcCtD
Modafinil—Body temperature increased—Gabapentin—epilepsy syndrome	7.52e-06	0.000113	CcSEcCtD
Modafinil—Abdominal pain—Gabapentin—epilepsy syndrome	7.52e-06	0.000113	CcSEcCtD
Modafinil—Hypotension—Topiramate—epilepsy syndrome	7.48e-06	0.000112	CcSEcCtD
Modafinil—Warfarin—ALB—epilepsy syndrome	7.47e-06	0.00486	CrCbGaD
Modafinil—Asthenia—Pregabalin—epilepsy syndrome	7.44e-06	0.000112	CcSEcCtD
Modafinil—Methadone—CYP2C19—epilepsy syndrome	7.4e-06	0.00482	CrCbGaD
Modafinil—Pruritus—Pregabalin—epilepsy syndrome	7.34e-06	0.00011	CcSEcCtD
Modafinil—Vomiting—Valproic Acid—epilepsy syndrome	7.3e-06	0.00011	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.29e-06	0.00011	CcSEcCtD
Modafinil—Insomnia—Topiramate—epilepsy syndrome	7.24e-06	0.000109	CcSEcCtD
Modafinil—Rash—Valproic Acid—epilepsy syndrome	7.23e-06	0.000109	CcSEcCtD
Modafinil—Dermatitis—Valproic Acid—epilepsy syndrome	7.23e-06	0.000109	CcSEcCtD
Modafinil—Headache—Valproic Acid—epilepsy syndrome	7.19e-06	0.000108	CcSEcCtD
Modafinil—Paraesthesia—Topiramate—epilepsy syndrome	7.19e-06	0.000108	CcSEcCtD
Modafinil—Dyspnoea—Topiramate—epilepsy syndrome	7.13e-06	0.000107	CcSEcCtD
Modafinil—Somnolence—Topiramate—epilepsy syndrome	7.11e-06	0.000107	CcSEcCtD
Modafinil—Diarrhoea—Pregabalin—epilepsy syndrome	7.1e-06	0.000107	CcSEcCtD
Modafinil—Dyspepsia—Topiramate—epilepsy syndrome	7.04e-06	0.000106	CcSEcCtD
Modafinil—Atomoxetine—CYP2D6—epilepsy syndrome	7.04e-06	0.00458	CrCbGaD
Modafinil—Hypersensitivity—Gabapentin—epilepsy syndrome	7.01e-06	0.000105	CcSEcCtD
Modafinil—Decreased appetite—Topiramate—epilepsy syndrome	6.96e-06	0.000105	CcSEcCtD
Modafinil—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.91e-06	0.000104	CcSEcCtD
Modafinil—Fatigue—Topiramate—epilepsy syndrome	6.9e-06	0.000104	CcSEcCtD
Modafinil—Dizziness—Pregabalin—epilepsy syndrome	6.86e-06	0.000103	CcSEcCtD
Modafinil—Pain—Topiramate—epilepsy syndrome	6.84e-06	0.000103	CcSEcCtD
Modafinil—Constipation—Topiramate—epilepsy syndrome	6.84e-06	0.000103	CcSEcCtD
Modafinil—Asthenia—Gabapentin—epilepsy syndrome	6.82e-06	0.000103	CcSEcCtD
Modafinil—Nausea—Valproic Acid—epilepsy syndrome	6.82e-06	0.000102	CcSEcCtD
Modafinil—Pruritus—Gabapentin—epilepsy syndrome	6.73e-06	0.000101	CcSEcCtD
Modafinil—Vomiting—Pregabalin—epilepsy syndrome	6.6e-06	9.91e-05	CcSEcCtD
Modafinil—Feeling abnormal—Topiramate—epilepsy syndrome	6.59e-06	9.91e-05	CcSEcCtD
Modafinil—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.54e-06	9.83e-05	CcSEcCtD
Modafinil—Rash—Pregabalin—epilepsy syndrome	6.54e-06	9.83e-05	CcSEcCtD
Modafinil—Dermatitis—Pregabalin—epilepsy syndrome	6.53e-06	9.82e-05	CcSEcCtD
Modafinil—Diarrhoea—Gabapentin—epilepsy syndrome	6.51e-06	9.78e-05	CcSEcCtD
Modafinil—Headache—Pregabalin—epilepsy syndrome	6.5e-06	9.76e-05	CcSEcCtD
Modafinil—Ketoprofen—PTGS2—epilepsy syndrome	6.47e-06	0.00421	CrCbGaD
Modafinil—Urticaria—Topiramate—epilepsy syndrome	6.36e-06	9.55e-05	CcSEcCtD
Modafinil—Abdominal pain—Topiramate—epilepsy syndrome	6.33e-06	9.51e-05	CcSEcCtD
Modafinil—Body temperature increased—Topiramate—epilepsy syndrome	6.33e-06	9.51e-05	CcSEcCtD
Modafinil—Dizziness—Gabapentin—epilepsy syndrome	6.29e-06	9.45e-05	CcSEcCtD
Modafinil—Nausea—Pregabalin—epilepsy syndrome	6.16e-06	9.26e-05	CcSEcCtD
Modafinil—Vomiting—Gabapentin—epilepsy syndrome	6.05e-06	9.09e-05	CcSEcCtD
Modafinil—Rash—Gabapentin—epilepsy syndrome	6e-06	9.01e-05	CcSEcCtD
Modafinil—Dermatitis—Gabapentin—epilepsy syndrome	5.99e-06	9e-05	CcSEcCtD
Modafinil—Headache—Gabapentin—epilepsy syndrome	5.96e-06	8.95e-05	CcSEcCtD
Modafinil—Hypersensitivity—Topiramate—epilepsy syndrome	5.9e-06	8.86e-05	CcSEcCtD
Modafinil—Ketoprofen—ALB—epilepsy syndrome	5.77e-06	0.00375	CrCbGaD
Modafinil—Asthenia—Topiramate—epilepsy syndrome	5.74e-06	8.63e-05	CcSEcCtD
Modafinil—Fentanyl—ABCB1—epilepsy syndrome	5.71e-06	0.00372	CrCbGaD
Modafinil—Diphenhydramine—CYP2D6—epilepsy syndrome	5.68e-06	0.0037	CrCbGaD
Modafinil—Pruritus—Topiramate—epilepsy syndrome	5.66e-06	8.51e-05	CcSEcCtD
Modafinil—Nausea—Gabapentin—epilepsy syndrome	5.65e-06	8.49e-05	CcSEcCtD
Modafinil—Methadone—CYP2D6—epilepsy syndrome	5.49e-06	0.00357	CrCbGaD
Modafinil—Diarrhoea—Topiramate—epilepsy syndrome	5.48e-06	8.23e-05	CcSEcCtD
Modafinil—Phenytoin—ALB—epilepsy syndrome	5.43e-06	0.00353	CrCbGaD
Modafinil—Carbamazepine—ABCB1—epilepsy syndrome	5.33e-06	0.00347	CrCbGaD
Modafinil—Dizziness—Topiramate—epilepsy syndrome	5.29e-06	7.95e-05	CcSEcCtD
Modafinil—Phenytoin—ABCB1—epilepsy syndrome	5.18e-06	0.00337	CrCbGaD
Modafinil—Vomiting—Topiramate—epilepsy syndrome	5.09e-06	7.64e-05	CcSEcCtD
Modafinil—Rash—Topiramate—epilepsy syndrome	5.05e-06	7.58e-05	CcSEcCtD
Modafinil—Dermatitis—Topiramate—epilepsy syndrome	5.04e-06	7.57e-05	CcSEcCtD
Modafinil—Headache—Topiramate—epilepsy syndrome	5.01e-06	7.53e-05	CcSEcCtD
Modafinil—Nausea—Topiramate—epilepsy syndrome	4.75e-06	7.14e-05	CcSEcCtD
Modafinil—Methadone—ABCB1—epilepsy syndrome	3.92e-06	0.00255	CrCbGaD
Modafinil—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	2.48e-06	0.000145	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCR3—epilepsy syndrome	2.46e-06	0.000143	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.45e-06	0.000143	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—COX3—epilepsy syndrome	2.44e-06	0.000142	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ADSL—epilepsy syndrome	2.43e-06	0.000142	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	2.4e-06	0.00014	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	2.4e-06	0.00014	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NPY—epilepsy syndrome	2.39e-06	0.000139	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ATP2A2—epilepsy syndrome	2.39e-06	0.000139	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GLUL—epilepsy syndrome	2.38e-06	0.000139	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	2.34e-06	0.000136	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	2.33e-06	0.000136	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AQP1—epilepsy syndrome	2.33e-06	0.000136	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AGT—epilepsy syndrome	2.33e-06	0.000136	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	2.31e-06	0.000135	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	2.31e-06	0.000135	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	2.31e-06	0.000135	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PFKL—epilepsy syndrome	2.31e-06	0.000135	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	2.31e-06	0.000135	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HSPB1—epilepsy syndrome	2.31e-06	0.000135	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—OXT—epilepsy syndrome	2.31e-06	0.000135	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CRH—epilepsy syndrome	2.31e-06	0.000135	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL2—epilepsy syndrome	2.31e-06	0.000135	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCL3—epilepsy syndrome	2.31e-06	0.000135	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CCR5—epilepsy syndrome	2.28e-06	0.000133	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	2.27e-06	0.000132	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NT5E—epilepsy syndrome	2.27e-06	0.000132	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALAD—epilepsy syndrome	2.27e-06	0.000132	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.24e-06	0.00013	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—HTR2A—epilepsy syndrome	2.23e-06	0.00013	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	2.22e-06	0.000129	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	2.21e-06	0.000129	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	2.2e-06	0.000128	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	2.19e-06	0.000128	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	2.17e-06	0.000126	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	2.17e-06	0.000126	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	2.16e-06	0.000126	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.15e-06	0.000125	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	2.15e-06	0.000125	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTK2B—epilepsy syndrome	2.15e-06	0.000125	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TSC1—epilepsy syndrome	2.15e-06	0.000125	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AQP1—epilepsy syndrome	2.12e-06	0.000124	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	2.12e-06	0.000124	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AGT—epilepsy syndrome	2.12e-06	0.000123	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.11e-06	0.000123	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.11e-06	0.000123	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.11e-06	0.000123	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	2.11e-06	0.000123	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	2.11e-06	0.000123	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NTRK2—epilepsy syndrome	2.09e-06	0.000122	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SST—epilepsy syndrome	2.09e-06	0.000122	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCR2—epilepsy syndrome	2.09e-06	0.000122	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ADSL—epilepsy syndrome	2.08e-06	0.000121	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—DUSP6—epilepsy syndrome	2.07e-06	0.000121	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ADRA2A—epilepsy syndrome	2.04e-06	0.000119	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.04e-06	0.000119	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GLUL—epilepsy syndrome	2.04e-06	0.000119	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.04e-06	0.000119	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PLAT—epilepsy syndrome	2.04e-06	0.000119	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	2e-06	0.000116	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	1.99e-06	0.000116	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.97e-06	0.000115	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.97e-06	0.000115	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL12—epilepsy syndrome	1.96e-06	0.000114	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BDKRB2—epilepsy syndrome	1.96e-06	0.000114	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.96e-06	0.000114	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—POMC—epilepsy syndrome	1.96e-06	0.000114	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PRKCB—epilepsy syndrome	1.95e-06	0.000114	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6ST—epilepsy syndrome	1.95e-06	0.000113	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	1.94e-06	0.000113	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—JUNB—epilepsy syndrome	1.93e-06	0.000112	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CNR1—epilepsy syndrome	1.93e-06	0.000112	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.92e-06	0.000112	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.92e-06	0.000112	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.92e-06	0.000112	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PLCB1—epilepsy syndrome	1.92e-06	0.000112	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	1.89e-06	0.00011	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—BCHE—epilepsy syndrome	1.88e-06	0.00011	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HTR7—epilepsy syndrome	1.88e-06	0.00011	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.87e-06	0.000109	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.85e-06	0.000108	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	1.85e-06	0.000108	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—BCHE—epilepsy syndrome	1.84e-06	0.000107	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HBEGF—epilepsy syndrome	1.83e-06	0.000106	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.82e-06	0.000106	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.8e-06	0.000105	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	1.8e-06	0.000105	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT3—epilepsy syndrome	1.79e-06	0.000104	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.79e-06	0.000104	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—POMC—epilepsy syndrome	1.78e-06	0.000104	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	1.78e-06	0.000104	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—TH—epilepsy syndrome	1.77e-06	0.000103	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	1.76e-06	0.000102	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.75e-06	0.000102	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.75e-06	0.000102	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.75e-06	0.000102	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ADAM10—epilepsy syndrome	1.75e-06	0.000102	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.74e-06	0.000102	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CCL2—epilepsy syndrome	1.74e-06	0.000102	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	1.74e-06	0.000101	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—TH—epilepsy syndrome	1.73e-06	0.000101	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.72e-06	0.0001	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.67e-06	9.74e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.67e-06	9.74e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.66e-06	9.69e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—S100B—epilepsy syndrome	1.65e-06	9.64e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.65e-06	9.62e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.64e-06	9.57e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.64e-06	9.57e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SOCS3—epilepsy syndrome	1.64e-06	9.55e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.64e-06	9.53e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDC42—epilepsy syndrome	1.63e-06	9.53e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.6e-06	9.34e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AVP—epilepsy syndrome	1.58e-06	9.22e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.57e-06	9.16e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.57e-06	9.13e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.54e-06	8.99e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.53e-06	8.91e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.53e-06	8.89e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.52e-06	8.84e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.51e-06	8.78e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.51e-06	8.77e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.5e-06	8.75e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.5e-06	8.73e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HES1—epilepsy syndrome	1.5e-06	8.72e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.48e-06	8.61e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.46e-06	8.5e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FYN—epilepsy syndrome	1.46e-06	8.48e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—H2AFX—epilepsy syndrome	1.45e-06	8.45e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MEF2C—epilepsy syndrome	1.45e-06	8.44e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.44e-06	8.42e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.44e-06	8.41e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.43e-06	8.33e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.43e-06	8.31e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.42e-06	8.29e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.42e-06	8.27e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.4e-06	8.16e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.4e-06	8.15e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.39e-06	8.08e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	1.38e-06	8.06e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.37e-06	8e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.37e-06	7.98e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.36e-06	7.91e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	1.35e-06	7.84e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.34e-06	7.83e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.34e-06	7.8e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TH—epilepsy syndrome	1.34e-06	7.8e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.32e-06	7.68e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.32e-06	7.68e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	1.32e-06	7.67e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.3e-06	7.6e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.3e-06	7.59e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.3e-06	7.56e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.3e-06	7.55e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.29e-06	7.51e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.29e-06	7.5e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.27e-06	7.38e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.27e-06	7.38e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	1.25e-06	7.29e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	1.25e-06	7.28e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.24e-06	7.21e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.22e-06	7.14e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	1.22e-06	7.14e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TH—epilepsy syndrome	1.22e-06	7.11e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.2e-06	7e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	1.2e-06	6.99e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.17e-06	6.84e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.17e-06	6.82e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.16e-06	6.74e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	1.15e-06	6.73e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	1.15e-06	6.7e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.13e-06	6.6e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.13e-06	6.59e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.12e-06	6.51e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.11e-06	6.49e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.11e-06	6.46e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.11e-06	6.45e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.1e-06	6.42e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.07e-06	6.25e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.06e-06	6.16e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	1.05e-06	6.13e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.05e-06	6.1e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TH—epilepsy syndrome	1.04e-06	6.08e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.03e-06	6.02e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	1.03e-06	6e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.03e-06	5.98e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.02e-06	5.93e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.01e-06	5.87e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CAT—epilepsy syndrome	1e-06	5.85e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1e-06	5.83e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GPX1—epilepsy syndrome	9.96e-07	5.81e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	9.77e-07	5.7e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—POMC—epilepsy syndrome	9.73e-07	5.67e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—POMC—epilepsy syndrome	9.51e-07	5.54e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	9.3e-07	5.42e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GPX1—epilepsy syndrome	9.09e-07	5.29e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	9.03e-07	5.26e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALB—epilepsy syndrome	8.87e-07	5.17e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AGT—epilepsy syndrome	8.74e-07	5.09e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	8.7e-07	5.07e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALB—epilepsy syndrome	8.67e-07	5.05e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	8.63e-07	5.03e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	8.59e-07	5.01e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CAT—epilepsy syndrome	8.59e-07	5e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOE—epilepsy syndrome	8.56e-07	4.99e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—BCHE—epilepsy syndrome	8.56e-07	4.99e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	8.47e-07	4.93e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	8.35e-07	4.87e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	8.16e-07	4.76e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	8.07e-07	4.71e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TH—epilepsy syndrome	8.05e-07	4.69e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AGT—epilepsy syndrome	7.97e-07	4.64e-05	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	7.86e-07	4.58e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOE—epilepsy syndrome	7.81e-07	4.55e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	7.79e-07	4.54e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GPX1—epilepsy syndrome	7.76e-07	4.52e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	7.76e-07	4.52e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	7.59e-07	4.42e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	7.56e-07	4.41e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	7.36e-07	4.29e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—POMC—epilepsy syndrome	7.35e-07	4.29e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	7.14e-07	4.16e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AGT—epilepsy syndrome	6.81e-07	3.97e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	6.78e-07	3.95e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	6.72e-07	3.91e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—POMC—epilepsy syndrome	6.71e-07	3.91e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALB—epilepsy syndrome	6.71e-07	3.91e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOE—epilepsy syndrome	6.67e-07	3.89e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CAT—epilepsy syndrome	6.63e-07	3.86e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	6.61e-07	3.85e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	6.45e-07	3.76e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALB—epilepsy syndrome	6.11e-07	3.56e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GPX1—epilepsy syndrome	5.99e-07	3.49e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	5.87e-07	3.42e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—POMC—epilepsy syndrome	5.73e-07	3.34e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	5.35e-07	3.12e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AGT—epilepsy syndrome	5.25e-07	3.06e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALB—epilepsy syndrome	5.22e-07	3.04e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.15e-07	3e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	4.57e-07	2.66e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.42e-07	2.58e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	4.22e-07	2.46e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.03e-07	2.35e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKT1—epilepsy syndrome	3.9e-07	2.27e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKT1—epilepsy syndrome	3.81e-07	2.22e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.53e-07	2.06e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKT1—epilepsy syndrome	2.95e-07	1.72e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.69e-07	1.57e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.3e-07	1.34e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.77e-07	1.03e-05	CbGpPWpGaD
